Pertuzumab, trastuzumab, and docetaxel for HER2-positive breast cancer

Rose M. Cheng, James Waddell, Dominic A. Solimando

Research output: Contribution to journalReview article

1 Citation (Scopus)

Abstract

The complexity of cancer chemotherapy requires pharmacists be familiar with the complicated regimens and highly toxic agents used. This column reviews various issues related to preparation, dispensing, and administration of antineoplastic therapy, and the agents, both commercially available and investigational, used to treat malignant diseases.

Original languageEnglish (US)
Pages (from-to)35-38
Number of pages4
JournalHospital Pharmacy
Volume51
Issue number1
DOIs
StatePublished - Jan 1 2016

Fingerprint

docetaxel
Poisons
Pharmacists
Antineoplastic Agents
Breast Neoplasms
Drug Therapy
Chemotherapy
Neoplasms
Therapeutics
Trastuzumab
pertuzumab

All Science Journal Classification (ASJC) codes

  • Pharmacy
  • Pharmacology
  • Pharmacology (medical)

Cite this

Pertuzumab, trastuzumab, and docetaxel for HER2-positive breast cancer. / Cheng, Rose M.; Waddell, James; Solimando, Dominic A.

In: Hospital Pharmacy, Vol. 51, No. 1, 01.01.2016, p. 35-38.

Research output: Contribution to journalReview article

Cheng, Rose M. ; Waddell, James ; Solimando, Dominic A. / Pertuzumab, trastuzumab, and docetaxel for HER2-positive breast cancer. In: Hospital Pharmacy. 2016 ; Vol. 51, No. 1. pp. 35-38.
@article{3ebfc04dbd5a42fd88148a3f68146b3e,
title = "Pertuzumab, trastuzumab, and docetaxel for HER2-positive breast cancer",
abstract = "The complexity of cancer chemotherapy requires pharmacists be familiar with the complicated regimens and highly toxic agents used. This column reviews various issues related to preparation, dispensing, and administration of antineoplastic therapy, and the agents, both commercially available and investigational, used to treat malignant diseases.",
author = "Cheng, {Rose M.} and James Waddell and Solimando, {Dominic A.}",
year = "2016",
month = "1",
day = "1",
doi = "10.1310/hpj5101-35",
language = "English (US)",
volume = "51",
pages = "35--38",
journal = "Hospital Pharmacy",
issn = "0018-5787",
publisher = "Facts and Comparisons",
number = "1",

}

TY - JOUR

T1 - Pertuzumab, trastuzumab, and docetaxel for HER2-positive breast cancer

AU - Cheng, Rose M.

AU - Waddell, James

AU - Solimando, Dominic A.

PY - 2016/1/1

Y1 - 2016/1/1

N2 - The complexity of cancer chemotherapy requires pharmacists be familiar with the complicated regimens and highly toxic agents used. This column reviews various issues related to preparation, dispensing, and administration of antineoplastic therapy, and the agents, both commercially available and investigational, used to treat malignant diseases.

AB - The complexity of cancer chemotherapy requires pharmacists be familiar with the complicated regimens and highly toxic agents used. This column reviews various issues related to preparation, dispensing, and administration of antineoplastic therapy, and the agents, both commercially available and investigational, used to treat malignant diseases.

UR - http://www.scopus.com/inward/record.url?scp=85020465123&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85020465123&partnerID=8YFLogxK

U2 - 10.1310/hpj5101-35

DO - 10.1310/hpj5101-35

M3 - Review article

AN - SCOPUS:85020465123

VL - 51

SP - 35

EP - 38

JO - Hospital Pharmacy

JF - Hospital Pharmacy

SN - 0018-5787

IS - 1

ER -